Gene expression analysis using Oncomine database revealed that although FSIP2 mRNA levels did not differ significantly between RCC patients and healthy controls, FSIP2 was significantly upregulated in papillary RCC. This evidence concerns the gene FSIP2 and renal cell carcinoma.